1. (J0516) Treatment of Patients with Hepatocellular Carcinoma Using Drug-Eluting Bead Embolization
2. (J0598) Phase II Trial of Bevacizumab with Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma
3. (J0660B) Therasphere for the Treatment of Liver Metastases: Open Label Trial of Therasphere in Patients with Liver Metastases from Primary Colorectal Cancer, Neuroendocrine Cancer or Non-Colorectal/Non-Neuroendocrine Cancer
4. (J0671) Prospective Analysis of Liver Cancer Treatments and Interventions
5. ( J0739) Treatment of Patients with Hepatic Neuroendocrine Metastases using Drug-Eluting Bead Embolization
6. (J08110) Phase II Trial of Sorafenib Combined with Doxorubicin Eluting Bead-Transarterial Chemoembolization (LC Bead-TACE) for Patients with Hepatocellular Carcinoma
7. (J0905) Global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with Sorafenib
If you would like more information, please call Diane Reyes at (410) 614-4212.
